Truecare Biomedix Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Truecare Biomedix Pharmaceutical Export Portfolio Dataset — 4 Products, $12.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Truecare Biomedix — Pharmaceutical Exporter Profile (2026) | 4 Products, $12.0M Trade | TransData Nexus

Truecare Biomedix

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $12.0M Total Trade · DGFT Verified

Truecare Biomedix is an Indian pharmaceutical exporter with a total trade value of $12.0M across 4 products in 3 therapeutic categories. Based on 436 verified export shipments from Indian Customs (DGFT) records, Truecare Biomedix is the #1 Indian exporter in 1 product including Docusate. Top exports include Docusate ($5.9M), Diphenhydramine ($2.2M), Acetaminophen ($2.1M).

Truecare Biomedix — Export Portfolio & Destination Treemap

Truecare Biomedix pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Truecare Biomedix? — Company Overview & Market Position

Truecare Biomedix is an Indian pharmaceutical exporter specializing in the development, manufacturing, and global supply of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2008, the company operates as a 100% Export Oriented Unit (E.O.U.) under the ownership structure of its parent company, Nuvicare LLC. Headquartered in Vadodara, Gujarat, India, Truecare Biomedix has a manufacturing facility located in Balasinor, Mahisagar, Gujarat. The company is registered with the Corporate Identification Number (CIN) U24230GJ2008PTC054019. While specific revenue figures are not publicly disclosed, the company has demonstrated a consistent export performance, with a total export value of $12.0 million USD and 436 shipments across 4 products in 2022-2026. The workforce comprises approximately 51-100 employees, reflecting a dedicated team committed to quality and innovation. For more information, the company's official website is www.tcbiomedix.com.

What Does Truecare Biomedix Export? — Product Portfolio Analysis

Top Products by Export Value

1Docusate$5.9M 2

Product Portfolio — Top 4 by Export Value

Truecare Biomedix exports 4 pharmaceutical products across 3 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Docusate	Gastrointestinal	$5.9M	136	63.2%	1
2	Diphenhydramine	Antihistamines & Allergy	$2.2M	114	6.9%	5
3	Acetaminophen	Analgesics & Antipyretics	$2.1M	91	0.9%	10
4	Aspirin	Analgesics & Antipyretics	$1.9M	95	5.0%	5

Truecare Biomedix exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $12.0M. The company is the #1 Indian exporter in 1 product: Docusate. The top category is Gastrointestinal (48.8% of portfolio), followed by Analgesics & Antipyretics (32.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Truecare Biomedix — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Truecare Biomedix operates a manufacturing facility in Balasinor, Mahisagar, Gujarat, India. This plant is fully compliant with current Good Manufacturing Practice (cGMP) standards, ensuring the production of high-quality pharmaceutical products. The facility is capable of producing a wide range of solid oral dosage forms, including tablets and capsules, with a monthly production capacity of 200 million tablets and 50 million capsules. Additionally, the plant is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating adherence to international manufacturing standards.

3Key Leadership

Specific details regarding the CEO, CFO, and other key executives of Truecare Biomedix are not publicly disclosed. However, the company's leadership emphasizes a commitment to quality and customer service, as evidenced by their mission to deliver dependable products and efficient service to customers. The management team focuses on building a system-driven organization, providing ample opportunities for employees to contribute to the company's growth and success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Truecare Biomedix Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Truecare Biomedix has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. Additionally, the facility operates in full compliance with the latest cGMP standards, ensuring the production of high-quality pharmaceutical products. While specific regulatory approvals in the EU, UK, Australia, and Japan are not detailed in the available sources, the company's adherence to cGMP and FDA standards suggests a commitment to meeting the regulatory requirements of these markets.

2Emerging Markets

Truecare Biomedix has expanded its operations to emerging markets, including Africa, Latin America, and Southeast Asia. The company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. While specific details regarding WHO prequalification are not available, the company's adherence to cGMP and FDA standards suggests a commitment to meeting the regulatory requirements of these emerging markets.

Geographic Strategy

Truecare Biomedix — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Truecare Biomedix's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. The facility has multiple FDA registrations for various products, including acetaminophen 500 mg tablets, with the most recent registration dated July 17, 2024. (fda.report) This indicates that Truecare Biomedix's products are recognized and approved for export to the United States, reflecting the company's commitment to meeting stringent regulatory standards.

2WHO & EU GMP

Specific details regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certifications for Truecare Biomedix are not publicly available. However, the company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. Additionally, the facility operates in full compliance with the latest cGMP standards, ensuring the production of high-quality pharmaceutical products.

3CDSCO & Indian Regulatory

Truecare Biomedix — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Truecare Biomedix operates in the competitive pharmaceutical export market, focusing on finished pharmaceutical formulations. While specific competitors are not detailed in the available sources, the company's adherence to cGMP and FDA standards positions it favorably in the market. The company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. Additionally, the facility operates in full compliance with the latest cGMP standards, ensuring the production of high-quality pharmaceutical products.

2Key Differentiators

Truecare Biomedix's key differentiators include its commitment to quality, as evidenced by its adherence to cGMP and FDA standards, and its focus on customer service, aiming to provide dependable products and efficient service to customers. The company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Truecare Biomedix as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Truecare Biomedix has demonstrated a consistent export performance, with a total export value of $12.0 million USD and 436 shipments across 4 products in 2022-2026. The company's manufacturing facility in India is registered as a 100% Export Oriented Unit (E.O.U.) and has been inspected by the US Food and Drug Administration (FDA), indicating compliance with international manufacturing standards. Additionally, the facility operates in full compliance with the latest cGMP standards, ensuring the production of high-quality pharmaceutical products.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Truecare Biomedix

How many pharmaceutical products does Truecare Biomedix export from India?

Truecare Biomedix exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Docusate ($5.9M), Diphenhydramine ($2.2M), Acetaminophen ($2.1M), Aspirin ($1.9M). Total export value is $12.0M.

What is Truecare Biomedix's total pharmaceutical export value?

Truecare Biomedix's total pharmaceutical export value is $12.0M, based on 436 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Truecare Biomedix the #1 Indian exporter?

Truecare Biomedix is the #1 Indian exporter in 1 products: Docusate (63.2% market share).

What therapeutic categories does Truecare Biomedix cover?

Truecare Biomedix exports across 3 therapeutic categories. The largest are Gastrointestinal (48.8%, 1 products), Analgesics & Antipyretics (32.9%, 2 products), Antihistamines & Allergy (18.4%, 1 products).

Get Full Truecare Biomedix Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.